Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | EP300 | Q09472 | 1/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.34 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.34 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | PPARG | P37231 | 2/20 | 0.33 |
| ▸ | GPR132 | Q9UNW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7543887 | 0.81 | ALDH1A1 (0.44) | MAPTALDH1A1EP300CYP3A4CYP2C9 | |
| SCHEMBL7543892 | 0.81 | ALDH1A1 (0.44) | MAPTALDH1A1EP300CYP3A4CYP2C9 | |
| SCHEMBL31079543 | 0.79 | EP300 (0.49) | MAPTALDH1A1EP300GPR84FFAR1 | |
| SCHEMBL29199613 | 0.78 | ALDH1A1 (0.43) | MAPTALDH1A1EP300CYP3A4PPARG | |
| SCHEMBL4559831 | 0.75 | EP300 (0.69) | MAPTEP300CYP2C9PPARG | |
| SCHEMBL3794524 | 0.75 | EP300 (0.69) | MAPTEP300CYP2C9PPARG | |
| SCHEMBL4559570 | 0.75 | EP300 (0.69) | MAPTEP300CYP2C9PPARG | |
| SCHEMBL4559828 | 0.75 | EP300 (0.69) | MAPTEP300CYP2C9PPARG | |
| SCHEMBL3794261 | 0.75 | EP300 (0.69) | MAPTEP300CYP2C9PPARG | |
| SCHEMBL3682579 | 0.75 | EP300 (0.69) | MAPTEP300CYP2C9PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8119839-B2 | Carboxylic acid and antidepressant composition containing the same as active ingredient | YAMADA APICULTURE CENTER, INC. (JP) | 2012-02-21 | — | — | US | disclosed |
| US-20100184860-A1 | Novel Carboxylic Acid and Antidepressant Composition Containing the Same as Active Ingredient | YAMADA APICULTURE CENTER, INC. (JP) | 2010-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100184860-A1 | Novel Carboxylic Acid and Antidepressant Composition Containing the Same as Active Ingredient | HSD17B11, HCAR2, HSD11B1 | MAPT 2782/4885ALDH1A1 109/4885EP300 1311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.